- Open Access
Factors associated with prolonged postoperative length of hospital stay after laparoscopic colorectal cancer resection: a secondary analysis of a randomized controlled trial
BMC Surgery volume 22, Article number: 438 (2022)
The postoperative length of hospital stay (PLOS) is an important indicator of surgical quality. We identified perioperative factors that affect prolonged PLOS (PPLOS) after laparoscopic colorectal cancer resection, which is the preferred surgical approach for colorectal cancer, the third most common cancer.
This study was a secondary analysis of a randomized trial (clinicaltrials.gov ID: NCT03160144) that included 280 patients who underwent laparoscopic colorectal cancer resection. The primary outcome was a PPLOS, defined as a PLOS that was longer than the median PLOS. Baseline, anesthetic, surgical, and postoperative management factors were included in the univariate and multivariate analyses to identify factors influencing PPLOS.
The median PLOS was 10 days, and 117 patients had a PPLOS. We identified six influencing factors for PPLOS: preoperative pulse oxygen saturation < 96% (odds ratio [OR], 3.09 [95% confidence interval (CI) 1.38–6.92]; P = 0.006), distant tumor metastasis (OR, 0.34 [95% CI 0.13–0.91]; P = 0.031), the Miles procedure or left hemicolectomy (OR, 4.51 [95% CI 1.67–12.18]; P = 0.003), perioperative surgical events (OR, 2.44 [95% CI 1.25–4.76]; P = 0.009), postoperative albumin infusion (OR, 2.19 [95% CI 1.14–4.19]; P = 0.018), and postoperative early ambulation (OR, 0.35 [95% CI 0.18–0.68]; P = 0.002). Further stratified analysis showed that postoperative albumin infusion might be a risk factor for PPLOS, even in patients with a preoperative albumin level < 40 g/L (OR, 2.29 [95% CI 0.98–5.34]; P = 0.056) or duration of surgery ≥ 3 h (OR, 2.52 [95% CI 1.08–5.87]; P = 0.032).
A low preoperative pulse oximetry reading, complex surgical procedures, perioperative surgical events, and postoperative albumin infusion may be risk factors for PPLOS after laparoscopic colorectal cancer resection, whereas distant tumor metastasis and postoperative early ambulation might be protective factors. The association between postoperative albumin infusion, a modifiable factor, and PLOS or clinical outcomes warrants further investigation.
Length of hospital stay (LOS) is at the core of many quality improvement initiatives, as it can reflect the quality of care delivered to patients and is associated with health care costs. Accordingly, a prolonged LOS usually denotes poor quality of medical care and higher medical expenses. In surgical patients, the postoperative LOS (PLOS) is a particularly important component of overall LOS, and shortening the PLOS is one of the goals of enhanced recovery after surgery (ERAS) . Therefore, understanding the factors that influence prolonged PLOS (PPLOS) in patients undergoing surgery is essential.
Colorectal cancer is the third most common cancer , and laparoscopic colorectal cancer resection is an important treatment option [3, 4]. The use of ERAS for laparoscopic colorectal cancer resection has become a popular topic recently [5,6,7]. Previous studies [4, 8,9,10,11,12] have shown that numerous factors were associated with PLOS after abdominal surgery, including age, smoking status, American Society of Anesthesiologists (ASA) physical status, preexisting medical conditions, surgical approach, duration of surgery, intraoperative lung-protective ventilation, surgical team's expertise, blood loss, blood transfusion, surgical complications, early postoperative mobilization, and postoperative nutritional status. However, factors that influence prolonged hospitalization after laparoscopic colorectal cancer resection remain unclear.
The PROtective Ventilation using Open Lung approach Or Not (PROVOLON) trial was a prospective, randomized controlled trial that investigated a lung-protective ventilation strategy on postoperative complications after laparoscopic colorectal cancer resection . The main results of this trial have been previously published . As a secondary outcome of the trial, the median PLOS did not differ between the lung-protective ventilation group and the non-lung-protective ventilation group . In this secondary analysis of the PROVOLON trial findings, we aimed to investigate the influencing factors, particularly modifiable factors, for PPLOS after laparoscopic colorectal cancer resection.
Ethics approval and consent to participate
The PROVOLON trial was a prospective, randomized, controlled trial. The Institutional Ethical Committee of the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China approved the study on January 9, 2017 (approval number: 2017ZSLYEC-002). The trial was registered at clinicaltrials.gov (ID: NCT03160144). Written informed consent was obtained from all the participants before enrolment. All experiments were performed in accordance with relevant guidelines and regulations. The trial included 280 patients, and the main results have been published .
Study design, setting, and participants
This was a secondary analysis of the PROVOLON trial, which was conducted from January 2017 to October 2018 at the Sixth Affiliated Hospital, Sun Yat-sen University, a comprehensive tertiary hospital in Guangzhou, China known for gastrointestinal surgery.
The inclusion and exclusion criteria for the trial have been previously described . Briefly, patients were eligible for inclusion if they were aged 40 years or older with a body mass index (BMI) < 30 kg/m2, had an intermediate-to-high risk of developing postoperative pulmonary complications, and were scheduled for laparoscopic colorectal cancer resection with an expected duration of pneumoperitoneum > 1.5 h. Patients were excluded if they were classified as ASA physical status ≥ IV, had a pulmonary infection or respiratory failure within 1 month, had cardiac failure, had severe chronic obstructive pulmonary disease or pulmonary bullae, had a progressive neuromuscular illness, or were participating in another interventional study. In the original study, patients were randomized to two ventilatory interventions during surgery: low tidal volume ventilation with or without an open-lung strategy (lung-protective ventilation or non-lung-protective ventilation).
Perioperative management, data extraction and relevant definitions
We obtained detailed preoperative, intraoperative and postoperative data from the PROVOLON trial team.
Postoperative hospital discharge was determined by the attending surgeon based on the discharge criteria after colorectal cancer surgery in our center: (1) the patient was generally in good condition and has basically returned to a normal diet and intestinal function; (2) The body temperature was normal, without positive signs upon abdominal examination, and the results of related laboratory tests were normal or close to normal; and (3) The incision has healed without surgical site infection.
Postoperative management was performed at the attending surgeons’ discretion. Drainage, blood product infusion, hypotension within 3 days after surgery, and other relevant events (including gallstones, kidney stones, intraperitoneal hyperthermic perfusion chemotherapy, and radiofrequency ablation of hepatic metastasis) were obtained from the follow-up data and hospital information system.
Intraoperative surgical events were defined as positive anastomotic leakage test, reoperation or intestinal anastomosis performed twice, duration of non-pneumoperitoneum ≥ 2 h, or abdominal drainage ≥ 200 mL in the post-anesthesia care unit. Early ambulation was defined as the patient being up and ambulatory within 2 days after surgery. The baseline mean arterial pressure (MAP) was defined as the mean value of three preoperative MAP values. Postoperative hypotension was defined as a decrease in MAP > 30% compared with the baseline MAP.
In the original study, PLOS was a secondary outcome, with no significant difference in the per-protocol population between the two groups . In the present study, we reanalyzed the PLOS in all enrolled patients. The PLOS was defined as the interval between the operation date and the discharge date.
The primary outcome was a PPLOS, defined as a PLOS longer than the median PLOS. According to the definition of PPLOS, the patients were divided into two groups: the control group (patients without a PPLOS) and the case group (patients with a PPLOS).
Predictors of PPLOS
We assessed several perioperative variables as possible risk factors, including preoperative characteristics (age, sex, BMI, hemoglobin level, white blood cell count, C-reactive protein [CRP] level, albumin level, pulse oxygen saturation [SpO2], ASA physical status, cardiocerebrovascular events, chemotherapy, radiotherapy, weight loss ≥ 10%, diabetes mellitus, abdominal surgery history, medical insurance, and tumor TNM stage), intraoperative characteristics (duration of surgery, chief surgeon, surgical approach, additional operation, active enterostomy, intraoperative surgical events, blood loss, lung-protective ventilation, blood product infusion, urine output, lactic acid, hemoglobin level, and glucose level), and postoperative characteristics (hypotension, albumin infusion, early ambulation, physiotherapy, blood product infusion, abdominal drainage, hemoglobin level, albumin level, white blood cell count, high-sensitivity CRP level, and other relevant events).
No power analysis was performed as the incidence of PPLOS in the study population has never been reported in the literature.
Continuous variables are described as mean and standard deviation or as median (25th, 75th percentiles) and were compared using an independent t test or the Mann–Whitney U test, as appropriate. Categorical variables are reported as numbers (proportions) and were compared using the Fisher exact test.
Variables considered clinically relevant or variables with a P-value < 0.1 in univariate analysis were introduced into the multivariate logistic regression model. Numerical or multi-categorical variables were transformed into two- or three-category variables before being entered into the multivariable logistic regression model. For example, we combined similar surgical procedures (e.g., anterior rectal cancer resection [Dixon] and sigmoidectomy) or the procedures with similar trends for PPLOS (e.g., coloanal anastomosis [Parks] and right hemicolectomy) into the same category to form a three-category variable. Variables with missing data were not included in multivariate analysis. Once a final list of variables was constructed, a stepwise logistic regression analysis was performed to examine the relationship between potential influencing factors and PPLOS. The final multivariate model was tested for goodness of fit using the Hosmer–Lemeshow test. The identified influencing factors are presented as odds ratios (ORs) with 95% confidence intervals (CIs).
After identifying the influencing factors for PPLOS, we conducted a further analysis of the association between clinical characteristics and postoperative albumin infusion. Additionally, we conducted a stratified univariate logistic regression analysis (stratification factors: preoperative albumin level and duration of surgery) of the association between postoperative albumin infusion and PPLOS.
Statistical analyses were conducted using SPSS Statistics for Windows, version 17.0 (SPSS Inc., Chicago, IL, USA). All P-values were two-sided, and a P-value < 0.05 was considered statistically significant.
According to the median PLOS (10 days), all 280 patients were divided into two groups (Fig. 1): the control group (PLOS ≤ 10 days, 163 cases) and case group (PLOS ≥ 11 days, 117 cases).
As shown in Tables 1, 2, 3, 4, nine possible influencing factors with a P-value < 0.1 were introduced into the multivariate logistic regression model, including the preoperative SpO2 (P = 0.008), distant tumor metastasis (P = 0.003), surgical approach (P = 0.001), chief surgeon (P = 0.052), duration of surgery ≥ 3 h (P = 0.05), blood loss ≥ 100 mL (P = 0.019), perioperative surgical events (P = 0.001), postoperative albumin infusion (P = 0.002), and postoperative early ambulation (P = 0.001). ASA physical status (P = 0.12) and lung-protective ventilation (P = 0.15) were also introduced into the multivariate logistic regression model based on clinical experience and the literature[12, 14, 15].
Finally, six influencing factors were identified, as shown in Table 5: preoperative SpO2 < 96% (OR, 3.09 [95% CI 1.38–6.92]; P = 0.006), distant tumor metastasis (OR, 0.34 [95% CI 0.13–0.91]; P = 0.031), the Miles procedure or left hemicolectomy (OR, 4.51 [95% CI 1.67–12.18]; P = 0.003), perioperative surgical events (OR, 2.44 [95% CI 1.25–4.76]; P = 0.009), postoperative albumin infusion (OR, 2.19 [95% CI 1.14–4.19]; P = 0.018), and postoperative early ambulation (OR, 0.35 [95% CI 0.18–0.68]; P = 0.002). The goodness of fit of the final multiple regression model was good (Hosmer–Lemeshow test, χ2 = 3.463, P = 0.749).
Postoperative albumin infusion was not related to preoperative nutritional status (preoperative albumin level, preoperative hemoglobin level, age, BMI, ASA physical status, radiotherapy, chemotherapy, and diabetes mellitus; all, P ≥ 0.05), but it was related to surgical factors (duration of surgery ≥ 3 h, blood loss ≥ 100 mL, and perioperative surgical events) (see Additional file 1: Table S1). Further stratified analysis showed that postoperative albumin infusion might be associated with PPLOS, even in patients with a preoperative albumin level < 40 g/L (OR, 2.29 [95% CI 0.98–5.34]; P = 0.056) or duration of surgery ≥ 3 h (OR, 2.52 [95% CI 1.08–5.87]; P = 0.032) (Table 5).
This study showed that a preoperative SpO2 < 96%, the Miles procedure or left hemicolectomy, perioperative surgical events, postoperative albumin infusion, distant tumor metastasis, and postoperative early ambulation were associated with PPLOS after laparoscopic colorectal cancer resection. We further found that postoperative albumin infusion was an independent and modifiable risk factor for PPLOS. This study is based on the data of a randomized trial; therefore, it was possible to comprehensively evaluate the association between perioperative factors (baseline, anesthesia, surgery, and postoperative management) and PPLOS.
We found that 38.5% of the patients in the case group had postoperative surgical complications (see Additional file 1: Table S2), that longer duration of surgery, perioperative surgical events, more intraoperative blood loss, and a suboptimal chief surgeon were all related to PPLOS than in their counterparts (Tables 3, 4), suggesting that surgical factors were the main influencing factors for PPLOS after laparoscopic colorectal cancer resection. However, multivariate analysis found that other factors were also related to PPLOS. It indicated that PPLOS resulted from a combination of surgical and multiple factors [14, 16]. Herein, variables related to anesthesia, such as intraoperative lung-protective ventilation, urine volume, and lactic acid level, were not associated with PPLOS. This may be related to the fact that the sample size of this study was still small; it also suggested that anesthetic factors might have less effect on PLOS than surgical factors and the patients’ baseline characteristics.
Inconsistent with previous studies [14, 15], we did not find an association between ASA physical status and PPLOS. We reasoned that the sample size was small, and only patients with an ASA physical status of II–III were enrolled in the study. In the present study, the incidence of postoperative pulmonary complications was higher and the median PLOS was longer than that reported previously [7, 17]. This discrepancy may be related to the included older patients (mean age: 70.3 years) with an intermediate-to-high risk for postoperative pulmonary complications.
A low preoperative pulse oximetry reading was a risk factor, whereas age was not associated with PPLOS in this study. A possible explanation is that there is an interaction between the heart and lung, and damage to both organs could lead to a decrease in SpO2 . These results suggest that cardiorespiratory status, rather than age, has an important effect on PLOS [15, 16]. We found that PPLOS was more likely to occur in patients undergoing the Miles procedure or left hemicolectomy than in those undergoing other surgical procedures. This might be related to more complex surgical procedures and greater trauma in these two procedures compared with other surgical procedures [16, 17].
We found that distant tumor metastasis was a protective factor against PPLOS. We speculate that this may be related to the conservative surgical strategies used on these patients so that they tend to have a shorter operation time, less bleeding and fewer intraoperative surgical events though there was no statistical difference (see Additional file 1: Table S3). However, we should be cautious about this result because it resulted from a special population (older age with a risk for pulmonary complications) and was inconsistent with the results of a previous study with a large sample size . ERAS pathways have been widely implemented in colorectal surgery to reduce physiological stress induced by surgery and postoperative complications [1, 20] and are associated with a significantly reduced PLOS in many different areas of surgery [6, 21]. Herein, postoperative early ambulation, as an important strategy for ERAS, was found to be a protective factor for PPLOS after laparoscopic colorectal cancer resection, which further demonstrates the importance of ERAS in promoting early recovery.
Postoperative hypoalbuminemia is often considered to be related to poor prognosis [22, 23]. Postoperative albumin infusion is usually used to reduce tissue edema, improve wound healing, and reduce complications [24, 25]. These considerations were also reflected in this study (see Additional file 1: Table S1). However, we found that postoperative albumin infusion was a risk factor for PPLOS in patients with preoperative hypoalbuminemia and in those with a longer duration of surgery (Table 5). Numerous studies [22, 26] have supported this conclusion and found that postoperative albumin infusion did not improve clinical outcomes and that albumin infusion was positively correlated with surgical complications, peritoneal hemorrhage, and pancreatic fistula. We reasoned that postoperative albumin infusion could neither increase the plasma albumin level to normal (see Additional file 1: Table S1) nor change the comprehensive nutritional status of the body. On the contrary, exogenous albumin infusion disrupts the nutritional balance of the body and increases the risk of adverse reactions, e.g., allergies. Therefore, postoperative albumin infusion may be a risk factor. However, this result needs to be further verified in larger samples, especially in prospective clinical trials. Since postoperative albumin infusion is a common and modifiable postoperative management behavior, and if it can be determined as a risk factor, changing this clinical behavior would improve the clinical outcomes of patients and decrease medical costs. Therefore, this study and any related clinical research that will be conducted in the future have important clinical significance.
This study had several limitations. First, the study population was patients undergoing laparoscopic colorectal cancer resection; therefore, the external reliability of its conclusions needs to be further verified. However, the incidence of colorectal cancer is high; therefore, studies on the factors influencing PPLOS in this population also have very important clinical significance. Second, the PROVOLON trial was not specifically designed to study PLOS, which may have led to differences in the postoperative discharge criteria. Nevertheless, our unit is well known for colorectal cancer surgery, and bed resources are limited; thus, we believe that subjective factors had little effect on PLOS in this study. Third, the diagnosis of postoperative complications might have been missed in 20 patients due to missing follow-up data in the PROVOLON trial. However, postoperative complications were not the primary outcome of this study. In addition, all postoperative complications in this study were re-diagnosed using postoperative follow-up data, medical records, imaging findings, and laboratory test results. Lastly, the sample size of this case–control study was small. However, this study was a secondary analysis of a prospective randomized controlled trial with detailed data; hence, its reliability is still high.
In conclusion, a low preoperative pulse oximetry reading, complex surgical procedures, postoperative albumin infusion, and perioperative surgical events may be risk factors for PPLOS after laparoscopic colorectal cancer resection, whereas postoperative early ambulation and distant tumor metastasis might be protective factors. Further studies on the association between postoperative albumin infusion and PLOS or clinical outcomes are warranted and meaningful.
Availability of data and materials
The data for this study are available from the corresponding author on reasonable request.
Length of hospital stay
Postoperative length of hospital stay
Enhanced recovery after surgery
Prolonged postoperative length of hospital stay
PROtective Ventilation using Open Lung approach Or Not
Body mass index
American Society of Anesthesiologists
Mean arterial pressure
- SpO2 :
Pulse oxygen saturation
Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152:292–8.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:329–59.
Schiphorst AH, Verweij NM, Pronk A, Borel Rinkes IH, Hamaker ME. Non-surgical complications after laparoscopic and open surgery for colorectal cancer—a systematic review of randomised controlled trials. Eur J Surg Oncol. 2015;41:1118–27.
Kennedy RH, Francis EA, Wharton R, Blazeby JM, Quirke P, West NP, et al. Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL. J Clin Oncol. 2014;32:1804–11.
Nelson G, Kiyang LN, Crumley ET, Chuck A, Nguyen T, Faris P, et al. Implementation of enhanced recovery after surgery (ERAS) across a provincial healthcare system: the ERAS Alberta colorectal surgery experience. World J Surg. 2016;40:1092–103.
Wahl TS, Goss LE, Morris MS, Gullick AA, Richman JS, Kennedy GD, et al. Enhanced recovery after surgery (ERAS) eliminates racial disparities in postoperative length of stay after colorectal surgery. Ann Surg. 2018;268:1026–35.
Mege D, Michelassi F. Readmission after abdominal surgery for Crohn’s disease: identification of high-risk patients. J Gastrointest Surg. 2018;22:1585–92.
Narendra K, Kiss N, Margerison C, Johnston B, Chapman B. Impact of nutritional status/risk and post-operative nutritional management on clinical outcomes in patients undergoing gastrointestinal surgery: a prospective observational study. J Hum Nutr Diet. 2020;33:587–97.
Fukuta A, Saito T, Murata S, Makiura D, Inoue J, Okumura M, et al. Impact of preoperative cachexia on postoperative length of stay in elderly patients with gastrointestinal cancer. Nutrition. 2019;58:65–8.
Mallard SR, Clifford KA, Park R, Cousins K, Patton A, et al. Role for colorectal teams to support non-colorectal teams to improve clinical outcomes and adherence to ERAS guidelines for segmental colectomy: a cohort study. BMC Surg. 2021;21:132.
Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428–37.
Li H, Zheng ZN, Zhang NR, Guo J, Wang K, Wang W, et al. Intra-operative open-lung ventilatory strategy reduces postoperative complications after laparoscopic colorectal cancer resection: a randomised controlled trial. Eur J Anaesthesiol. 2021;38:1042–51.
Holloway S, Sarosi G, Kim L, Nwariaku F, O’Keefe G, Hynan L, et al. Health-related quality of life and postoperative length of stay for patients with colorectal cancer. J Surg Res. 2002;108:273–8.
Shin JI, Kim JS, Steinberger J, DiCapua J, Cho SK. Patient factors contributing to prolonged postoperative length of stay and increased rate of readmission after elective posterior cervical fusion. Clin Spine Surg. 2018;31:E55–61.
Jo YY, Han J, Park HW, Jung H, Lee JD, Jung J, et al. Prediction of prolonged length of hospital stay after cancer surgery using machine learning on electronic health records: retrospective cross-sectional study. JMIR Med Inform. 2021;9: e23147.
Hoffman RL, Bartlett EK, Ko C, Mahmoud N, Karakousis GC, Kelz RR. Early discharge and readmission after colorectal resection. J Surg Res. 2014;190:579–86.
Garutti I, Errando CL, Mazzinari G, Bellon JM, Diaz-Cambronero O, Ferrando C, et al. Spontaneous recovery of neuromuscular blockade is an independent risk factor for postoperative pulmonary complications after abdominal surgery: a secondary analysis. Eur J Anaesthesiol. 2020;37:203–11.
Aravani A, Samy EF, Thomas JD, Quirke P, Morris EJA, Finan PJ. A retrospective observational study of length of stay in hospital after colorectal cancer surgery in England (1998–2010). Medicine. 2016;95: e5064.
Adamina M, Kehlet H, Tomlinson GA, Senagore AJ, Delaney CP. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery. 2011;149:830–40.
Teigen NC, Sahasrabudhe N, Doulaveris G, Xie X, Negassa A, Bernstein J, et al. Enhanced recovery after surgery at cesarean delivery to reduce postoperative length of stay: a randomized controlled trial. Am J Obstet Gynecol. 2020;222(372):e1–10.
Xu W, Peng X, Jiang B. Hypoalbuminemia after pancreaticoduodenectomy does not predict or affect short-term postoperative prognosis. BMC Surg. 2020;20:72.
Li JD, Diao YK, Li J, Wu H, Sun LY, Gu WM, et al. Association between preoperative prealbumin level and postoperative mortality and morbidity after hepatic resection for hepatocellular carcinoma: a multicenter study from a HBV-endemic area. Am J Surg. 2021;221:1024–32.
Navarro LH, Bloomstone JA, Auler JO Jr, Cannesson M, Rocca GD, Gan TJ, et al. Perioperative fluid therapy: a statement from the international fluid optimization group. Perioper Med (Lond). 2015;4:3.
Hasselgren E, Zdolsek M, Zdolsek JH, Bjorne H, Krizhanovskii C, Ntika S, et al. Long intravascular persistence of 20% albumin in postoperative patients. Anesth Analg. 2019;129:1232–9.
Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87:198–210.
We would like to thank the Cancer Database of The Sixth Affiliated Hospital, Sun Yat-sen University for supplying the postoperative data. We acknowledge Qian Wu from the Clinical Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, for his valuable advice regarding the statistical analyses. We would like to thank Editage (www.editage.cn) for English language editing.
This study was funded by the Medical Scientific Research Foundation of Guangdong Province (A2017045, China). The funding body has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Ethics approval and consent to participate
Ethical approval for this study was obtained from the Institutional Review Board of the Sixth Affiliated Hospital of Sun Yat-sen University (Approval Number: 2017ZSLYEC-002). Written informed consent was obtained from all participants before enrolment. All experiments were performed in accordance with relevant guidelines and regulations.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1
: Table S1. The associations between clinical characteristics and postoperative albumin infusion. Table S2. Postoperative complications. Table S3. Operation and tumor metastasis.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Li, H., Luo, TF., Zhang, NR. et al. Factors associated with prolonged postoperative length of hospital stay after laparoscopic colorectal cancer resection: a secondary analysis of a randomized controlled trial. BMC Surg 22, 438 (2022). https://doi.org/10.1186/s12893-022-01886-4
- Postoperative length of hospital stay
- Colorectal surgery